Skip to content

Drug interactions

Irinotecan liposomal + Mifepristone

Severity: Major

Irinotecan liposomal and Mifepristone: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Irinotecan is activated and detoxified by several pathways, including CYP3A4 oxidation to inactive metabolites. Inhibition of CYP3A4 may raise exposure to irinotecan and its active metabolite SN-38, increasing risk of neutropenia and diarrhea.

What this interaction means in plain words

Irinotecan liposomal and Mifepristone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Low

Why it happens

Mifepristone inhibits CYP3A4 and may alter irinotecan metabolism, increasing exposure to active species.

What to do

Avoid strong CYP3A4 inhibitors with irinotecan where possible. If combined, monitor blood counts and diarrhea closely.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Irinotecan liposomal and Mifepristone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Irinotecan liposomal with Mifepristone?

MediHelp rates the interaction as major. Irinotecan liposomal and Mifepristone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Irinotecan is activated and detoxified by several pathways, including CYP3A4 oxidation to inactive metabolites. Inhibition of CYP3A4 may raise exposure to irinotecan and its active metabolite SN-38, increasing risk of neutropenia and diarrhea.

How serious is the interaction between Irinotecan liposomal and Mifepristone?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid strong CYP3A4 inhibitors with irinotecan where possible. If combined, monitor blood counts and diarrhea closely.

What other medicines interact with Mifepristone?

MediHelp also lists interactions of Mifepristone with, for example, Apixaban, Argatroban, Cisapride. The full list is on the Mifepristone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in